Thuraiaiyah, Janu
Kokoti, Lili
Al-Karagholi, Mohammad Al-Mahdi
Ashina, Messoud
Funding for this research was provided by:
Lundbeckfonden (R310-2018-3711)
Article History
Received: 29 November 2021
Accepted: 10 March 2022
First Online: 5 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: JT, LK and MMK report no conflict of interest. MA has received consulting fees and honoraria for lectures/presentations from AbbVie, Allergan, Amgen, Eli Lily, Lundbeck, Novartis and Teva. MA has also received personal payments for participating on data Safety Monitoring Board or Advisory Board for AbbVie, Amgen, Eli Lily, Lundbeck and Novartis.